FRAILTY,FALL RISK AND PROTEIN ENERGY WASTING IN HEMODIALYSIS PATIENTS
- Conditions
- Unspecified kidney failure,
- Registration Number
- CTRI/2025/05/086471
- Lead Sponsor
- NANCY EMELDA S
- Brief Summary
The study will be proceeded after getting approval from the institutional ethical committee (IEC).Patients will be selected based on the inclusion and exclusion criteria .Informed consent will be obtained from the patients to ensure their willingness in this study.The need for the study will be clearly explained to the patients in their Regional language.The frailty will be assessed from the participants by asking the questions form the Edmonton frailty scale which is administered by the researcher.The person who’s score ranges from 8 to 17 is considered frail.The protein energy wasting will be assessed using the subjective global assessment.The nutritional status of the individual participants can be taken from the medical records.The fall risks for the CKD patients will be assessed using the fall risk assessment tool.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 111
The patients with chronic kidney disease(CKD),The male and female above 18 years,Patients undergoing haemodialysis for more than 3 months, The patient who have ability to understand the informed consent and sign it,Ambulating patients.
Patients with any cognitive Impairment, Patients whose recent medical records are unavailable, Patients with disabilities other than CKD (Amputations, other balance disorders due to neurological impairment), Patients involved in other clinical trials receiving experimental treatments that may affect outcomes, Renal transplanted patients, Patient undergoing peritoneal dialysis, Any active Neoplastic or infectious disease.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO INVESTIGATE THE RELATIONSHIP BETWEEN THE FRAILTY,FALL RISK AND PROTEIN ENERGY WASTING(PEW) IN HEMODIALYSIS PATIENTS 8-12 weeks
- Secondary Outcome Measures
Name Time Method TO EXPLORE THE ASSOCIATION OF DEMOGRAPHIC AND CLINICAL FACTORS SUCH AS AGE,GENDER,COMORBIDITIES WITH FRAILTY,FALL RISK AND PROTEIN ENERGY WASTING(PEW). 8-12 weeks
Trial Locations
- Locations (1)
SRM MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE
🇮🇳Kancheepuram, TAMIL NADU, India
SRM MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE🇮🇳Kancheepuram, TAMIL NADU, IndiaDr KAVIYA MPrincipal investigator9940513772kaviyam3@srmist.edu.in